Masayuki Nakagawa spends much of his time researching microRNA, Cancer, Cancer research, Molecular biology and Cell growth. His microRNA research is multidisciplinary, relying on both Gene expression, Carcinogenesis, RNA interference, Regulation of gene expression and Gene silencing. His Cancer research is multidisciplinary, incorporating elements of Oncology and Transfection.
He combines subjects such as Bladder cancer, RNA, Cell cycle, Oncogene and Tumor suppressor gene with his study of Cancer research. His biological study spans a wide range of topics, including Camptothecin, Cell culture, Northern blot and Gene expression profiling. His Cell growth study combines topics in areas such as Cell cycle checkpoint and Apoptosis.
Masayuki Nakagawa mostly deals with Cancer research, microRNA, Cancer, Internal medicine and Oncology. His research integrates issues of Bladder cancer, Carcinogenesis, Renal cell carcinoma, Metastasis and Prostate cancer in his study of Cancer research. His work carried out in the field of microRNA brings together such families of science as Gene expression, Cell growth, Molecular biology, Cell cycle and Gene silencing.
His Molecular biology study integrates concerns from other disciplines, such as Cell culture and Gene expression profiling. His Cancer study incorporates themes from Signal transduction, Gene and Pathology. His Internal medicine research includes elements of Gastroenterology, Endocrinology and DNA methylation.
His main research concerns Cancer research, microRNA, Bladder cancer, Internal medicine and Renal cell carcinoma. Masayuki Nakagawa has included themes like Cell growth, Carcinogenesis, Apoptosis, Clear cell renal cell carcinoma and Sunitinib in his Cancer research study. His Carcinogenesis research focuses on Cell cycle and how it relates to Regulation of gene expression.
The microRNA study combines topics in areas such as Cancer cell, Cancer, Metastasis, Cell culture and Gene silencing. His studies deal with areas such as Molecular biology, Surgical oncology and Gene as well as Cancer. Masayuki Nakagawa interconnects Gastroenterology, Oncology and Microrna 26a in the investigation of issues within Internal medicine.
Masayuki Nakagawa focuses on microRNA, Cancer research, Cell growth, Bladder cancer and Cancer. His research in microRNA intersects with topics in Cell culture, Carcinogenesis, Metastasis, Regulation of gene expression and Gene silencing. His Cancer research research integrates issues from Apoptosis, Cell cycle, Gene knockdown, Clear cell renal cell carcinoma and Sunitinib.
His work in Cell growth addresses issues such as Cell, which are connected to fields such as Cell biology. His work deals with themes such as Gene, Position paper and General surgery, which intersect with Bladder cancer. Masayuki Nakagawa focuses mostly in the field of Cancer, narrowing it down to matters related to Molecular biology and, in some cases, Cell migration and Transfection.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma
Masayuki Kano;Naohiko Seki;Naoko Kikkawa;Lisa Fujimura.
International Journal of Cancer (2010)
Identification of novel microRNA targets based on microRNA signatures in bladder cancer.
Takahiro Ichimi;Hideki Enokida;Yasushi Okuno;Ryo Kunimoto.
International Journal of Cancer (2009)
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
T Chiyomaru;H Enokida;S Tatarano;K Kawahara.
British Journal of Cancer (2010)
Prognostic value of tumor-associated macrophage count in human bladder cancer
Toshikatsu Hanada;Masayuki Nakagawa;Akio Emoto;Takeo Nomura.
International Journal of Urology (2000)
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
H Yoshino;T Chiyomaru;H Enokida;K Kawakami.
British Journal of Cancer (2011)
MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology
Yasutoshi Yamada;Hideki Enokida;Satoko Kojima;Kazumori Kawakami.
Cancer Science (2011)
Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
Takeshi Chiyomaru;Soichiro Yamamura;Shinichiro Fukuhara;Hirofumi Yoshino.
PLOS ONE (2013)
Combination Analysis of Hypermethylated Wnt-Antagonist Family Genes as a Novel Epigenetic Biomarker Panel for Bladder Cancer Detection
Shinji Urakami;Hiroaki Shiina;Hideki Enokida;Toshifumi Kawakami.
Clinical Cancer Research (2006)
Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase ( PNP ) in prostate cancer
S Kojima;T Chiyomaru;K Kawakami;H Yoshino.
British Journal of Cancer (2012)
Aberrant expression of microRNAs in bladder cancer
Hirofumi Yoshino;Naohiko Seki;Toshihiko Itesako;Takeshi Chiyomaru.
Nature Reviews Urology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: